Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 35

1.

The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective.

Setiawan D, Luttjeboer J, Westra TA, Wilschut JC, Suwantika AA, Daemen T, Atthobari J, Wilffert B, Postma MJ.

Expert Rev Vaccines. 2014 Dec 6:1-16. [Epub ahead of print]

PMID:
25482311
[PubMed - as supplied by publisher]
2.

Cost-effectiveness of vaccination against herpes zoster.

de Boer PT, Wilschut JC, Postma MJ.

Hum Vaccin Immunother. 2014 Jul;10(7):2048-61. doi: 10.4161/hv.28670.

PMID:
25424815
[PubMed - in process]
3.

Dengue seroprevalence and risk factors for past and recent viral transmission in Venezuela: a comprehensive community-based study.

Velasco-Salas ZI, Sierra GM, Guzmán DM, Zambrano J, Vivas D, Comach G, Wilschut JC, Tami A.

Am J Trop Med Hyg. 2014 Nov 5;91(5):1039-48. doi: 10.4269/ajtmh.14-0127. Epub 2014 Sep 15.

PMID:
25223944
[PubMed - in process]
4.

Cost-effectiveness of the prophylactic HPV vaccine: an application to the Netherlands taking non-cervical cancers and cross-protection into account.

Luttjeboer J, Westra TA, Wilschut JC, Nijman HW, Daemen T, Postma MJ.

Vaccine. 2013 Aug 20;31(37):3922-7. doi: 10.1016/j.vaccine.2013.06.044. Epub 2013 Jun 24.

PMID:
23806241
[PubMed - indexed for MEDLINE]
5.

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

Westra TA, Stirbu-Wagner I, Dorsman S, Tutuhatunewa ED, de Vrij EL, Nijman HW, Daemen T, Wilschut JC, Postma MJ.

BMC Infect Dis. 2013 Feb 7;13:75. doi: 10.1186/1471-2334-13-75.

PMID:
23390964
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.

de Boer PT, Pouwels KB, Cox JM, Hak E, Wilschut JC, Postma MJ.

Vaccine. 2013 Feb 18;31(9):1276-83. doi: 10.1016/j.vaccine.2012.12.067. Epub 2013 Jan 8.

PMID:
23306360
[PubMed - indexed for MEDLINE]
7.

Nanoaggregates of micropurified lipopolysaccharide identified using dynamic light scattering, zeta potential measurement, and TLR4 signaling activity.

Hardy E, Kamphuis T, Japaridze A, Wilschut JC, Winterhalter M.

Anal Biochem. 2012 Nov 15;430(2):203-13. doi: 10.1016/j.ab.2012.08.027. Epub 2012 Sep 6.

PMID:
22960012
[PubMed - indexed for MEDLINE]
8.

Comparatively low attendance during Human Papillomavirus catch-up vaccination among teenage girls in the Netherlands: Insights from a behavioral survey among parents.

Gefenaite G, Smit M, Nijman HW, Tami A, Drijfhout IH, Pascal A, Postma MJ, Wolters BA, van Delden JJ, Wilschut JC, Hak E.

BMC Public Health. 2012 Jul 2;12:498. doi: 10.1186/1471-2458-12-498.

PMID:
22748022
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

On discounting of health gains from human papillomavirus vaccination: effects of different approaches.

Westra TA, Parouty M, Brouwer WB, Beutels PH, Rogoza RM, Rozenbaum MH, Daemen T, Wilschut JC, Boersma C, Postma MJ.

Value Health. 2012 May;15(3):562-7. doi: 10.1016/j.jval.2012.01.005. Epub 2012 Mar 29.

PMID:
22583467
[PubMed - indexed for MEDLINE]
10.

Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands.

Meijboom MJ, Rozenbaum MH, Benedictus A, Luytjes W, Kneyber MC, Wilschut JC, Hak E, Postma MJ.

Vaccine. 2012 Jun 29;30(31):4691-700. doi: 10.1016/j.vaccine.2012.04.072. Epub 2012 May 2.

PMID:
22561315
[PubMed - indexed for MEDLINE]
11.

Practical implications of differential discounting of costs and health effects in cost-effectiveness analysis.

Westra TA, Parouty MB, Wilschut JC, Boersma C, Postma MJ.

Value Health. 2011 Dec;14(8):1173-4; author reply 1174-5. doi: 10.1016/j.jval.2011.07.013. Epub 2011 Nov 12. No abstract available.

PMID:
22152190
[PubMed - indexed for MEDLINE]
12.

GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults.

Behzad H, Huckriede AL, Haynes L, Gentleman B, Coyle K, Wilschut JC, Kollmann TR, Reed SG, McElhaney JE.

J Infect Dis. 2012 Feb 1;205(3):466-73. doi: 10.1093/infdis/jir769. Epub 2011 Dec 5.

PMID:
22147791
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Until which age should women be vaccinated against HPV infection? Recommendation based on cost-effectiveness analyses.

Westra TA, Rozenbaum MH, Rogoza RM, Nijman HW, Daemen T, Postma MJ, Wilschut JC.

J Infect Dis. 2011 Aug 1;204(3):377-84. doi: 10.1093/infdis/jir281.

PMID:
21742836
[PubMed - indexed for MEDLINE]
Free Article
14.

Cost-effectiveness of rotavirus vaccination in the Netherlands; the results of a consensus model.

Rozenbaum MH, Mangen MJ, Giaquinto C, Wilschut JC, Hak E, Postma MJ; Consensus Group on Dutch Rotavirus Vaccination (CoRoVa-Group).

BMC Public Health. 2011 Jun 10;11:462. doi: 10.1186/1471-2458-11-462.

PMID:
21663620
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Needle-free influenza vaccination.

Amorij JP, Hinrichs WLj, Frijlink HW, Wilschut JC, Huckriede A.

Lancet Infect Dis. 2010 Oct;10(10):699-711. doi: 10.1016/S1473-3099(10)70157-2. Review. Erratum in: Lancet Infect Dis.2010 Nov;10(11):740.

PMID:
20883966
[PubMed - indexed for MEDLINE]
16.

Results of a retrospective database analysis of drug utilization and costs for treatment of chronic hepatitis B virus infection in the northern Netherlands between 2000 and 2006.

Tu HA, Bos JH, Woerdenbag HJ, Visser ST, Wilschut JC, van Assen S, de Jong-van den Berg LT, Postma MJ.

Clin Ther. 2010 Jan;32(1):133-44. doi: 10.1016/j.clinthera.2010.01.015.

PMID:
20171419
[PubMed - indexed for MEDLINE]
17.

[Dengue: a growing risk to travellers to tropical and sub-tropical regions].

da Silva-Voorham JM, Tami A, Juliana AE, Rodenhuis-Zybert IA, Wilschut JC, Smit JM.

Ned Tijdschr Geneeskd. 2009;153:A778. Review. Dutch.

PMID:
20025792
[PubMed - indexed for MEDLINE]
18.

[Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].

Westra TA, Daemen T, Postma MJ, Wilschut JC.

Ned Tijdschr Geneeskd. 2009;153:A356. Review. Dutch.

PMID:
19930733
[PubMed - indexed for MEDLINE]
19.

Cost-effectiveness of prophylactic vaccination against human papillomavirus 16/18 for the prevention of cervical cancer: adaptation of an existing cohort model to the situation in the Netherlands.

Rogoza RM, Westra TA, Ferko N, Tamminga JJ, Drummond MF, Daemen T, Wilschut JC, Postma MJ.

Vaccine. 2009 Jul 30;27(35):4776-83. doi: 10.1016/j.vaccine.2009.05.085. Epub 2009 Jun 17.

PMID:
19539578
[PubMed - indexed for MEDLINE]
20.

Role of antibodies in controlling dengue virus infection.

van der Schaar HM, Wilschut JC, Smit JM.

Immunobiology. 2009 Jul;214(7):613-29. doi: 10.1016/j.imbio.2008.11.008. Epub 2009 Mar 3. Review.

PMID:
19261353
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk